Literature DB >> 23773984

Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.

Vittorio Martinelli1, Bruno Colombo2, Gloria Dalla Costa2, Dacia Dalla Libera2, Lucia Moiola2, Andrea Falini3, Giancarlo Comi2, Massimo Filippi4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23773984     DOI： 10.1177/1352458513492246

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  13 in total

1.  Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.

Authors:  Maria Pia Amato; Antonio Bertolotto; Roberto Brunelli; Paola Cavalla; Benedetta Goretti; Maria Giovanna Marrosu; Francesco Patti; Carlo Pozzilli; Leandro Provinciali; Nicola Rizzo; Nicola Strobelt; Gioacchino Tedeschi; Maria Trojano; Giancarlo Comi
Journal:  Neurol Sci       Date:  2017-08-02       Impact factor: 3.307

Review 2.  Multiple sclerosis and pregnancy in the 'treatment era'.

Authors:  Sandra Vukusic; Romain Marignier
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

3.  Recurrence of disease activity after repeated Natalizumab withdrawals.

Authors:  Laura Ferrè; Lucia Moiola; Francesca Sangalli; Marta Radaelli; Valeria Barcella; Giancarlo Comi; Vittorio Martinelli
Journal:  Neurol Sci       Date:  2014-09-24       Impact factor: 3.307

4.  Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.

Authors:  Ludwig Kappos; Ernst-Wilhelm Radue; Giancarlo Comi; Xavier Montalban; Helmut Butzkueven; Heinz Wiendl; Gavin Giovannoni; Hans-Peter Hartung; Tobias Derfuss; Yvonne Naegelin; Till Sprenger; Nicole Mueller-Lenke; Sarah Griffiths; Philipp von Rosenstiel; Rebecca Gottschalk; Ying Zhang; Frank Dahlke; Davorka Tomic
Journal:  Neurology       Date:  2015-05-29       Impact factor: 9.910

Review 5.  Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

Authors:  Raed Alroughani; Ayse Altintas; Mohammed Al Jumah; Mohammadali Sahraian; Issa Alsharoqi; Abdurahman AlTahan; Abdulkader Daif; Maurice Dahdaleh; Dirk Deleu; Oscar Fernandez; Nikolaos Grigoriadis; Jihad Inshasi; Rana Karabudak; Karim Taha; Natalia Totolyan; Bassem I Yamout; Magd Zakaria; Saeed Bohlega
Journal:  Mult Scler Int       Date:  2016-12-18

Review 6.  Pregnancy, sex and hormonal factors in multiple sclerosis.

Authors:  David H Miller; Franz Fazekas; Xavier Montalban; Stephen C Reingold; Maria Trojano
Journal:  Mult Scler       Date:  2014-01-20       Impact factor: 6.312

7.  Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Authors:  Gitanjali Das; Vincent Damotte; Jeffrey M Gelfand; Carolyn Bevan; Bruce A C Cree; Lynn Do; Ari J Green; Stephen L Hauser; Riley Bove
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-03-19

8.  Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation.

Authors:  S K Vainio; A M Dickens; J Tuisku; O Eskola; O Solin; E Löyttyniemi; D C Anthony; J O Rinne; L Airas; M Haaparanta-Solin
Journal:  EJNMMI Res       Date:  2019-05-09       Impact factor: 3.138

9.  Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations.

Authors:  Beatriz Canibaño; Dirk Deleu; Boulenouar Mesraoua; Gayane Melikyan; Faiza Ibrahim; Yolande Hanssens
Journal:  J Drug Assess       Date:  2020-01-23

10.  Disease activity following pregnancy-related discontinuation of natalizumab in MS.

Authors:  Iris Kleerekooper; Zoé L E van Kempen; Cyra E Leurs; Iris Dekker; Theo Rispens; Birgit I Lissenberg-Witte; Caspar E P van Munster; Brigit A de Jong; Bob W van Oosten; Bernard M J Uitdehaag; Mike P Wattjes; Joep Killestein
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.